Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
49 hedge funds and large institutions have $18.7M invested in Vaxart in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 9 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
5% less capital invested
Capital invested by funds: $19.7M → $18.7M (-$989K)
8% less funds holding
Funds holding: 53 → 49 (-4)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$469K |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$445K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$32.8K |
| 4 |
Renaissance Technologies
New York
|
+$26.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$21.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$471K |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$215K |
| 3 |
Goldman Sachs
New York
|
-$53.6K |
| 4 |
SIM
Spark Investment Management
New York
|
-$36.7K |
| 5 |
Morgan Stanley
New York
|
-$35.6K |
VXRT Hedge Fund Activity: Q2 2016 in Review
49 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2016, worth a combined $18.7M — down 5% from $19.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of VXRT and 5 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 9 added.
The largest buyer was Vanguard Group, adding an estimated $469K. The largest seller was Fidelity Investments, cutting an estimated $471K.
- 49 institutional investors held Vaxart (VXRT) as of Q2 2016, down from 53 in Q1 2016.
- Funds reported $18.7M of Vaxart stock for Q2 2016, down 5% quarter-over-quarter.
- 5 funds opened new Vaxart positions in Q2 2016 and 9 closed out, a net change of -4 holders.
- The largest Vaxart buyer in Q2 2016 was Vanguard Group, an estimated $469K added.
- The largest Vaxart seller in Q2 2016 was Fidelity Investments, an estimated $471K sold.
Based on aggregated 13F filings for Q2 2016.